Coronavirus vaccine update: Nod to human trial marks 'beginning of the end', says govt
More than 140 candidate vaccines to cure COVID-19 infection, are under various stages of development
Indian manufacturers account for 60% of vaccine supplies made to UNICEF, said government
The approval for human trails for two made-in-India COVID-19 vaccines, marks the 'beginning of the end,' the government said today. Two COVID-19 vaccine candidates — Covaxin, developed by the Hyderabad-based Bharat Biotech International Limited in collaboration with the ICMR and the National Institute of Virology (NIV) and ZyCov-D vaccine by Zydus Cadila — had recently got the nod for human clinical trials from the Drug Controller General of India. Both have been approved for Phase II, III trials.